The asian pharmacoepidemiology network (AsPEN): Promoting multi-national collaboration for pharmacoepidemiologic research in Asia

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 7, 2013, Pages 700-704

  Andersen, Morten ^a,l   Bergman, Ulf ^a,l   Choi, Nam Kyong ^b,m   Gerhard, Tobias ^c,n   Huang, Cecilia ^c,n   Jalbert, Jessica ^d   Kimura, Michio ^e   Kimura, Tomomi ^e   Kubota, Kiyoshi ^f   Lai, Edward Chia Cheng ^g   Ooba, Nobuhiro ^f   Park, Byung Joo ^h,i   Pratt, Nicole ^j   Roughead, Elizabeth E ^j   Sato, Tsugumichi ^f   Setoguchi, Soko ^k   Shin, Ju Young ⁱ   Sundström, Anders ^a,l   Yang, Yea Huei Kao ^g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Seoul National University Hospital   (South Korea)

^c RUTGERS UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^h Seoul National University   (South Korea)

ⁱ Korea Institute of Drug Safety and Risk Management   (South Korea)

^j UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^k DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m Seoul National University College of Medicine   (South Korea)

ⁿ RUTGERS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ASIA; E-MAIL; EDUCATION; FEASIBILITY STUDY; GOVERNMENT; HUMAN; INTERPERSONAL COMMUNICATION; NOTE; PATIENT SAFETY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SIGNAL DETECTION; TELECONFERENCE; TRAINING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ASIA; COOPERATIVE BEHAVIOR; DATA MINING; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FORECASTING; HUMANS; INTERNATIONAL COOPERATION; PHARMACOEPIDEMIOLOGY; PHARMACOVIGILANCE;

EID: 84880046381     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3439     Document Type: Note

References (18)

1. Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR project. Pharmacoepidemiol Drug Saf 2011; 20: 1-11.
2. Behrman RE, Benner JS, Brown JS, et al. Developing the sentinel system-a national resource for evidence development. N Engl J Med 2011; 364: 498-499.
3. Furu K, Wettermark B, Andersen M, et al. The Nordic countries as a cohort fo pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2009; 106: 86-94.
4. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996; 7: 478-484.
5. Data Management and Information Systems, Department of Veterans' Affairs, Australia. http://www.dama.org.au/chapters/canberra/ [30 June 2011].
6. Japan Medical Data Center database: claims data assembled from a couple of private health insurance unions, Japan. http://www.jmdc.co.jp/en/mission/index.html [30 June 2011].
7. Watanabe H, Kimura T, Hori K, et al. Analytical clinical information retrieval system based on hospital information system-overview and use cases. Jpn J Pharmacoepidemiol 2010; 15: 97-106. (In Japanese)
8. Kimura M, Tani S, Watanabe H, et al. High speed clinical data retrieval system with event time sequence feature-with 10years of clinical data of Hamamatsu University Hospital CPOE. Methods Inf Med 2008; 47: 560-568.
9. Korea Health Insurance Review and Assessment Service (HIRA). Major Activities of HIRA. HIRA, Korea. http://hira.or.kr/cms/rb/rbb_english/13/13_01/01/review.html [15 June 2011].
10. Korea National Health Insurance Corporation (NHIC). Statistical Information. NHIC, Korea. http://stat.kosis.kr/nsieu/view/tree.do?task=branchView&id=350_35001_BMT_OTITLE&hOrg=350 [20 June 2011].
11. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726-735.
12. National Health Insurance Research Database (NHIRD), Taiwan. http://www.nhri.org.tw/nhird/en/index.htm [22 June 2011].
13. Crystal S, Akincigil A, Bilder S, et al. Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies. Med Care 2007; 45(10 Supl 2): S58-S65.
14. Centers for Medicare and Medicaid Services. Medicaid Analytic eXtract (MAX) General Information, Baltimore, MD. http://www.cms.gov/MedicaidDataSourcesGenInfo/07_MAXGeneralInformation.asp. [14 July 2011].
15. Adamson DM, Chang S, Hansen LG. White Paper: Health Research Data for the Real World: the MarketScan Databases. Thomson Medstat: Atlanta, GA, 2006.
16. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical code classification index with defined daily doses. http://www.whocc.no/atcddd [5 September 2011].
17. Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: The Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf 2013, in press
18. Asian Pharmacoepidemiology Network (AsPEN), AsPEN. http://www.aspennet.asia/index.html [1 June 2013].